Vectorite Biomedical Inc. (TPEX:4170)
Taiwan
· Delayed Price · Currency is TWD 13.45
-0.65 (-4.61%)
At close: Mar 9, 2026
Vectorite Biomedical Company Description
Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally.
It is involved in cell preparation product manufacturing; and collection and storage of immune cells.
The company’s products are used in the field of infectious diseases and inflammation, cancer, oncology.
Vectorite Biomedical Inc. was incorporated in 2004 and is based in New Taipei City, Taiwan.
Vectorite Biomedical Inc.
| Country | Taiwan |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Kechang Ou |
Contact Details
Address: No. 97, Xintai 5th Road New Taipei City, 22175 Taiwan | |
| Phone | 886 2 2697 1100 |
| Website | vectorite.com.tw |
Stock Details
| Ticker Symbol | 4170 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004170006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Kechang Ou | General Manager |